tiprankstipranks
BioMark Diagnostics (TSE:BUX)
CNQX:BUX

BioMark Diagnostics (BUX) Financial Statements

3 Followers

BioMark Diagnostics Financial Overview

BioMark Diagnostics's market cap is currently ―. The company's EPS TTM is C$-0.018; its P/E ratio is -11.96; BioMark Diagnostics is scheduled to report earnings on August 26, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total RevenueC$ 41.54KC$ 42.13KC$ 39.75KC$ 39.75KC$ 36.89K
Gross ProfitC$ 41.54KC$ 42.13KC$ 39.75KC$ 39.75KC$ 36.89K
EBITC$ -386.69KC$ -192.12KC$ -393.55KC$ -471.82KC$ -371.42K
EBITDAC$ -287.38KC$ -101.60KC$ -290.78KC$ -369.07KC$ -281.17K
Net Income Common StockholdersC$ -406.76KC$ -214.00KC$ -418.86KC$ -501.51KC$ -393.70K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 313.03KC$ 168.44KC$ 175.24KC$ 72.04KC$ 133.90K
Total AssetsC$ 1.35MC$ 632.24KC$ 722.81KC$ 732.29KC$ 884.60K
Total DebtC$ 1.08MC$ 516.44KC$ 737.64KC$ 823.87KC$ 908.30K
Net DebtC$ 770.53KC$ 347.99KC$ 562.41KC$ 751.83KC$ 774.40K
Total LiabilitiesC$ 1.91MC$ 1.78MC$ 1.86MC$ 1.88MC$ 1.75M
Stockholders EquityC$ -559.77KC$ -1.15MC$ -1.14MC$ -1.15MC$ -870.30K
Cash Flow-
Free Cash Flow--C$ -249.77K--
Operating Cash Flow-C$ -11.85KC$ -249.77KC$ -175.23KC$ -154.50K
Investing Cash Flow-C$ -957.00-C$ -1.00C$ -758.00
Financing Cash Flow-C$ 6.02KC$ 352.97KC$ 113.36KC$ 127.95K
Currency in CAD

BioMark Diagnostics Earnings and Revenue History

BioMark Diagnostics Debt to Assets

BioMark Diagnostics Cash Flow

BioMark Diagnostics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis